Latest Articles

Publication Date
AbbVie’s Phase 3b Study on Elagolix: A Potential Game-Changer for Endometriosis Treatment? - TipRanks

AbbVie’s Phase 3b Study on Elagolix: A Potential Game-Changer for Endometriosis Treatment? TipRanks

Published: Sept. 6, 2025, 4:33 a.m.
Is Elagolix The Magic Pill For Endometriosis? Dr Anjali Kumar Weighs In on the Pros, Cons, And What Women Need To Know - OnlyMyHealth

Is Elagolix The Magic Pill For Endometriosis? Dr Anjali Kumar Weighs In on the Pros, Cons, And What Women Need To Know OnlyMyHealth

Published: April 4, 2025, 9:01 a.m.
Recent Trends in Medical Management of Endometriosis.

Endometriosis affects about 10 percent women in the reproductive age group globally and approximately 42 million in India. Managing the patient's pain symptoms associated with endometriosis appears to be the …

Published: Dec. 26, 2024, midnight
Elagolix with add-back therapy found effective and tolerable for endometriosis pain - Contemporary Obgyn

Elagolix with add-back therapy found effective and tolerable for endometriosis pain Contemporary Obgyn

Published: Dec. 3, 2024, 6:36 p.m.
Elagolix Sodium Salt and Its Synthetic Intermediates: A Spectroscopic, Crystallographic, and Conformational Study.

Elagolix sodium salt is the first marketed orally active non-peptide gonadotropin-releasing hormone receptor antagonist (GnRHR-ant) for the management of hormone dependent diseases, such as endometriosis and uterine fibroids. Despite its …

Published: May 3, 2023, midnight
Changes in adenomyosis following elagolix vs leuprolide treatment in a patient with pelvic pain and infertility: A case report.

Adenomyosis is a uterine form of endometriosis that poses unique challenges in the management of infertility. Severe pelvic pain and menorrhagia associated with these conditions are commonly managed with intramuscular …

Published: Feb. 2, 2023, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!